Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diagnoses Disease

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospitals of Geneva (HUG)

Geneva, 1205, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.

Exclusion criteria

Exclusion criteria concerned patients who shared a common language with the doctor and/or were not able to read in their native language.

Treatment and study plan

the translation tool BabelDr

Device

Doctors use a speech-enabled fixed-phrase translation tool to help communicate with an allophone patient.

Primary outcomes

Satisfaction evaluation through a 4-point scale survey

Time frame: During the consultation

Are patients' and doctors' satisfied with the use of BabelDr?
Efficacy evaluation through a 2-point scale survey

Time frame: During the consultation

Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?
Technical features evaluation through a 4-point scale survey

Time frame: During the consultation

Are the technical features appreciated by the doctors'?

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Collaborators

University of Geneva, Switzerland

Registry information

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Mar 9, 2021
Registry last updated: Mar 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed